Abstract
Influenza has historically been and remains a significant global health concern, causing substantial illness worldwide. Influenza is a serious public health issue in both industrialized and developing nations and it is characterized as an acute respiratory illness resulting from infection with influenza virus. Influenza viruses are RNA viruses with a negative sense and enveloped structure. These viruses possess segmented genomes, with influenza A and B viruses being the prevalent types affecting human populations. These viruses have been associated with disease outbreaks in some regions of the world as a result of excrement being introduced into the environment. Given the global implications of influenza and the limited availability of data for many countries, particularly in the African region where the prevalence and incidence of influenza remain largely unknown, there is a lack of published information regarding the detection of influenza viruses. Therefore, the purpose of this paper is to examine or review the frequency of influenza virus detection in wastewater samples, serving as an initial step toward gaining a better understanding of the burden of influenza. This includes exploring its epidemiology, the consequences of severe influenza infections, and the development of strategies to enhance supportive care and virus-specific therapies in resource-constrained, low-income settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
AIO Grant Number: P790 Funder: South African Medical Research Council (SAMRC) www.samrc.ac.za The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. M D Grant number: 142122 Funder: National Research Foundation (NRF) nrfconnect.nrf.ac.za The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
N/A
